Medasil Surgical Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2021-2022🗂️ Report periods on file: 2021-2022

In its 2021-2022 reporting, Medasil Surgical Limited disclosed greenhouse gas emissions of 197.6K tCO2e. By scope: Scope 1: 25.0K tCO2e; Scope 2: 34.6K tCO2e; Scope 3: 145.0K tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
197.6K tCO2e
2021-2022

📊 Emissions by Scope (2021-2022)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).25.0K tCO2e
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.34.6K tCO2e
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).145.0K tCO2e

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔭 Long-term

  • Net Zero emissions by 2050

🌱 ESG Focus Areas

Climate Change

⚠️ Challenges & Risks +

  • High emissions from water use (85000 tCO2e in 2021, 137130 tCO2e in 2022)
  • Significant Scope 3 emissions

📋 Report Information

Reporting Period: 2021-2022
Frameworks: PPN 06/21, GHG Reporting Protocol corporate standard